Copyright
©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 329-337
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.329
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.329
ABOi (n = 30) | ABOc (n = 30) | P-value | |
Mean follow-up (mo) | 74 (14-114) | 78 (13-116) | ns |
Serum creatinine (mg/dL) | |||
1 yr after KTx | 1.56 ± 0.34 | 1.53 ± 0.46 | ns |
3 yr after KTx | 1.53 ± 0.37 | 1.5 ± 0.43 | ns |
5 yr after KTx | 1.6 ± 0.48 | 1.53 ± 0.55 | ns |
8 yr after KTx | 1.78 ± 0.57 | 1.76 ± 0.58 | ns |
eGFR by MDRD (mL/min per 1.73 m2) | |||
1 yr after KTx | 56.1 ± 13.4 | 56.3 ± 16.8 | ns |
3 yr after KTx | 51.5 ± 17.1 | 56.1 ± 16.1 | ns |
5 yr after KTx | 53.1 ± 17 | 54.5 ± 17.3 | ns |
8 yr after KTx | 47.3 ± 20.5 | 44.4 ± 16.4 | ns |
Rejections | |||
Acute cellular rejection | 4 (13.3%) | 3 (10%) | ns |
Acute antibody - mediated rejection | 0 (0%) | 0 (0%) | ns |
- Citation: Melexopoulou C, Marinaki S, Liapis G, Skalioti C, Gavalaki M, Zavos G, Boletis JN. Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center. World J Transplant 2015; 5(4): 329-337
- URL: https://www.wjgnet.com/2220-3230/full/v5/i4/329.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i4.329